Nutex Health Inc. - Common Stock (NUTX)
Industrials › Services-Business Services, NEC
Price History
Feb 9, 2026 — Aug 3, 2026Investment Snapshot
- Trading 3% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 8/9 — financially strong with improving fundamentals
- Strong ROE of 36.0% with 10.6% net margin
- Revenue growing at 82% annually
Nutex Health Inc. - Common Stock (NUTX) is a Industrials company operating in Services-Business Services, NEC, listed on the NASDAQ , with a market capitalisation of $1.0 billion . Key value metrics: P/E ratio 10.2, P/B ratio 2.26, Piotroski F-Score 8 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Nutex Health Inc. - Common Stock — Fundamental Analysis Summary
Nutex Health Inc. - Common Stock (NUTX) is currently trading 3% above its Graham Number of $143.05, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 10.2x.
On financial health, NUTX shows a strong Piotroski F-Score of 8/9, indicating improving fundamentals across profitability, leverage, and efficiency, and strong return on equity of 36.0% (sector average: 6.1%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for NUTX is 88/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
NUTX reports a solid gross margin of 52.1% (sector average: 14.5%) and a strong operating margin of 33.8%.
NUTX shows revenue growing at 82% year-over-year, with earnings growing at 36%.